169 related articles for article (PubMed ID: 25704120)
1. Novel antiviral compounds against gastroenteric viral infections.
Mohamed MS; Abd El-Hameed RH; Sayed AI; Soror SH
Arch Pharm (Weinheim); 2015 Mar; 348(3):194-205. PubMed ID: 25704120
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of novel pyrrolopyrimidine derivatives as antiviral against gastroenteric viral infections.
Mohamed MS; Sayed AI; Khedr MA; Nofal S; Soror SH
Eur J Pharm Sci; 2019 Jan; 127():102-114. PubMed ID: 30366078
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of some pyrrolo[2,3-d]pyrimidines.
Rashad AE; Mohamed MS; Zaki ME; Fatahala SS
Arch Pharm (Weinheim); 2006 Dec; 339(12):664-9. PubMed ID: 17149793
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents.
Ghorab MM; Ragab FA; Heiba HI; Youssef HA; El-Gazzar MG
Bioorg Med Chem Lett; 2010 Nov; 20(21):6316-20. PubMed ID: 20850308
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiviral evalution of some novel pyrazoles and pyrazolo[3,4-d]pyridazines bearing 5,6,7,8-tetrahydronaphthalene.
Hamdy NA; El-Senousy WM
Acta Pol Pharm; 2013; 70(1):99-110. PubMed ID: 23610964
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors.
Chern JH; Shia KS; Hsu TA; Tai CL; Lee CC; Lee YC; Chang CS; Tseng SN; Shih SR
Bioorg Med Chem Lett; 2004 May; 14(10):2519-25. PubMed ID: 15109643
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiviral evaluation of 2'-C-methyl analogues of 5-alkynyl- and 6-alkylfurano- and pyrrolo[2,3-d]pyrimidine ribonucleosides.
Januszczyk P; Fogt J; Boryski J; Izawa K; Onishi T; Neyts J; De Clercq E
Nucleosides Nucleotides Nucleic Acids; 2009 May; 28(5):713-23. PubMed ID: 20183611
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of certain pyrrole derivatives as antimicrobial agents.
Mohamed MS; El-Domany RA; Abd El-Hameed RH
Acta Pharm; 2009 Jun; 59(2):145-58. PubMed ID: 19564140
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antiproliferative, and antiviral activity of certain 4-substituted and 4,5-disubstituted 7-[(1,3-dihydroxy-2-propoxy)methyl]pyrrolo[2,3-d]pyrimidines.
Pudlo JS; Nassiri MR; Kern ER; Wotring LL; Drach JC; Townsend LB
J Med Chem; 1990 Jul; 33(7):1984-92. PubMed ID: 2163454
[TBL] [Abstract][Full Text] [Related]
10. New condensed pyrroles of potential biological interest syntheses and structure-activity relationship studies.
Mohamed MS; Kamel R; Fatahala SS
Eur J Med Chem; 2011 Jul; 46(7):3022-9. PubMed ID: 21549457
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line.
Jung MH; Kim H; Choi WK; El-Gamal MI; Park JH; Yoo KH; Sim TB; Lee SH; Baek D; Hah JM; Cho JH; Oh CH
Bioorg Med Chem Lett; 2009 Dec; 19(23):6538-43. PubMed ID: 19857963
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiviral activity of an imidazo[1,2-a]pyrrolo[2,3-c]pyridine series against the bovine viral diarrhea virus.
Chezal JM; Paeshuyse J; Gaumet V; Canitrot D; Maisonial A; Lartigue C; Gueiffier A; Moreau E; Teulade JC; Chavignon O; Neyts J
Eur J Med Chem; 2010 May; 45(5):2044-7. PubMed ID: 20149501
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity.
Renau TE; Wotring LL; Drach JC; Townsend LB
J Med Chem; 1996 Feb; 39(4):873-80. PubMed ID: 8632411
[TBL] [Abstract][Full Text] [Related]
14. A new series of HAPs as anti-HBV agents targeting at capsid assembly.
Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S
Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104
[TBL] [Abstract][Full Text] [Related]
15. Novel synthesis and antifungal activity of pyrrole and pyrrolo[2,3-d]pyrimidine derivatives containing sulfonamido moieties.
El-Gaby MS; Gaber AM; Atalla AA; Abd Al-Wahab KA
Farmaco; 2002 Aug; 57(8):613-7. PubMed ID: 12361227
[TBL] [Abstract][Full Text] [Related]
16. Novel cytomegalovirus-inhibitory compounds of the class pyrrolopyridines show a complex pattern of target binding that suggests an unusual mechanism of antiviral activity.
Hahn F; Hutterer C; Henry C; Hamilton ST; Strojan H; Kraut A; Schulte U; Schütz M; Kohrt S; Wangen C; Pfizer J; Couté Y; Rawlinson WD; Strobl S; Marschall M
Antiviral Res; 2018 Nov; 159():84-94. PubMed ID: 30268914
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives as antibacterial and antifungal agents.
Hilmy KM; Khalifa MM; Hawata MA; Keshk RM; el-Torgman AA
Eur J Med Chem; 2010 Nov; 45(11):5243-50. PubMed ID: 20828885
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, antiviral, antituberculostic and antibacterial activities of some novel, 4-(4'-substituted phenyl)-6-(4"-hydroxyphenyl)-2-(substituted imino) pyrimidines.
Siddiqui AA; Rajesh R; Mojahid-Ul-Islam ; Alagarsamy V; Meyyanathan SN; Kumar BP; Suresh B
Acta Pol Pharm; 2007; 64(1):17-26. PubMed ID: 17665846
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives and evaluation of their activities against human colon cancer cell lines.
Tangeda SJ; Garlapati A
Eur J Med Chem; 2010 Apr; 45(4):1453-8. PubMed ID: 20163895
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and thiosangivamycin: the effect of certain 4- and 4,6-substituents on the antiviral activity of pyrrolo[2,3-d]pyrimidines.
Renau TE; Kennedy C; Ptak RG; Breitenbach JM; Drach JC; Townsend LB
J Med Chem; 1996 Aug; 39(18):3470-6. PubMed ID: 8784444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
